Hemas Pharmaceuticals, first SL pharma company to be awarded COVID-19 Safety Management System Certification

Hemas Pharmaceuticals has become the first pharmaceutical company in Sri Lanka to be awarded the SLS 1672:2020 COVID-19 Safety Management System Certification from the Sri Lanka Standards Institution.

The certification has been awarded as a result of the company’s relevance, rigour and consistency in the implementation and reinforcement of best in class safety management practices to minimise the risks of COVID-19 within its work locations, the company said in a media release

Speaking on the certification, Jude Fernando, Managing Director of Hemas Pharmaceuticals said, “Creating a healthier nation begins first by ensuring the health and safety of our own employees from the risks of COVID-19 in our work locations during the current pandemic situation. We are proud to be the first in the industry and among very few corporates in Sri Lanka to have this endorsement at the highest level from the Sri Lanka Standards Institution for our COVID -19 related Health and Safety efforts.”